Charles River Laboratories International, Inc.

US$337.52As of Sun 8 Nov 2026, 12:00 UTC
NYSE:CRLHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 16.06%
Div yield —
ROE 1.27%
Diagnostics & Research
Beta (5Y) 1.34
PE TTM 407.3
TSR TTM 87.44%
Mkt cap US$16.17B
ROIC 9.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$338
0.03%
172.21%
Hold 9|4|4|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
5.82
6.32
7.06
7.00
33.43%
31.75%
31.55%
33.67%
Revenue$B
1.241
1.252
1.244
1.286
2.66%
2.96%
0.08%
6.46%
Peers (US$16.17B)
Cap (US$)
PE
18.27B
36.22x
17.31B
68.65x
17.00B
34.65x
Capital
TTM
5Y
10Y
Leveragex
1.419
(0.848)
(0.769)
EBIT/Intx
2.811
0.192
0.172
Own earn%
17.82
(54.69)
(54.80)
Sh yield%
18.52
14.97
14.47
Owners
Insiders/Inst%
6.28
82.65
Short interest%
4.57
SBC / revenue%
3.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
2